Stockreport

IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates

Imunon, Inc.  (IMNN) 
PDF Conference call today at 11:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage deve [Read more]